Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 24323 

Date: June 16–17, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Kee Forbes, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7806, Bethesda, MD 20892, 301–272– 

4865, pyonkh2@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Biomarkers Study Section. 

Date: June 16–17, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–357– 

9318 ngkl@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 19, 2022. 

David W Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08716 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request International 

Research Fellowship Award Program 

of the National Institute on Drug Abuse 

(NIDA) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institute on Drug Abuse 

(NIDA), National Institutes of Health 

(NIH) has submitted to the Office of 

Management and Budget (OMB) a 

request for review and approval of the 

information collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Lindsey 

Friend, Research Training Program 

Officer, NIDA International Program, 

National Institute on Drug Abuse, 

National Institutes of Health, 3WFN 

MSC 6024, 301 North Stonestreet 

Avenue, Bethesda, Maryland 20892, or 

call non-toll-free number (301) 402– 

1428 or email your request, including 

your address to: lindsey.friend@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on February 14, 2022, page 

8267 (87 FR 8267) and allowed 60 days 

for public comment. No public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. 

The National Institute on Drug Abuse 

(NIDA), National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: The 

International Research Fellowship 

Award Program of the National Institute 

on Drug Abuse (NIDA), 0925–0733, 

expiration date 07/31/2022, 

EXTENSION, National Institute on Drug 

Abuse (NIDA), National Institutes of 

Health (NIH). 

Need And Use of Information 

Collection: These programs offer grants 

and traineeships necessary for growing 

the biomedical researcher workforce, 

and the diversity in this workforce. The 

application forms collect information of 

applicants for selecting those that would 

benefit most effectively from the 

programs. NIDA is requesting approval 

from OMB for application forms to be 

used by these programs that will recruit 

pre-college through post-doctoral 

underrepresented individuals and 

individuals of special populations into 

the research programs of the Institute for 

research training and research 

development, for forging mentor/mentee 

relationships and networking between 

newly funded underrepresented 

researchers and experienced 

investigators funded by NIDA; and for a 

fellowship program to train new 

researchers, and support experienced 

researchers of other nations, in research 

to advance the biomedical and 

behavioral science of drug abuse and 

addiction while fostering multinational 

research in this disease area. The 

application forms will be web-based. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

annualized burden hours are 33. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

Applicant Scientists .......................................................................................... 25 1 1 25 

Scientists .......................................................................................................... 25 1 20/60 8 

Total .......................................................................................................... ........................ 50 ........................ 33 


khammond on DSKJM1Z7X2PROD with NOTICES
24324 Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 

Dated:April 20, 2022 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2022–08779 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Center for 

Advancing Translational Sciences 

Advisory Council. 

This meeting is being held virtually 

only; there is no in-person option. The 

open sessions will be videocast and may 

be accessed by the public from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov). Individuals 

who need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: May 19–20, 2022. 

Closed: May 19, 2022, 11:00 a.m. to 12:30 

p.m. 

Agenda: To review, evaluate, and discuss 

internal operations. To review and evaluate 

grant applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Open: May 19, 2022, 1:00 p.m. to 5:00 p.m. 

Agenda: Report from the Institute Director, 

Invited Speaker Presentation, and DPI 

Program Update. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Open: May 20, 2022, 1:00 p.m. to 5:00 p.m. 

Agenda: OSI Program Update; view and 

discuss Clearance of Concepts. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, 

National Institutes of Health One Democracy 

Plaza, Room 1072, 6701 Democracy 

Boulevard, Bethesda, MD 20892, 301–435– 

0809, anna.ramseyewing@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: April 20, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08715 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; HEAL Initiative: 

Developing Quantitative Imaging and Other 

Relevant Biomarkers of Myofascial Tissues 

for Clinical Pain Management. 

Date: May 19–20, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Complementary 

and Integrative Democracy II, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Shiyong Huang, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, Division of Extramural Activities, 

NCCIH/NIH, 6707 Democracy Boulevard, 

Suite 401, Bethesda, MD 20817, 

shiyong.huang@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: April 20, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08721 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; 3D Aging and 

Alzheimer Brain Program. 

Date: May 31, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Birgit Neuhuber, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

Ninds, NIH NSC, 6001 Executive Blvd., Suite 

3208, MSC 9529, Bethesda, MD 20892, 301– 

496–3562, neuhuber@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES